Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
NCT02083367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2015-05-25
Summary
Investigating the impact of hepatic encephalopathy on default mode networks within the brain to provide more clues with understanding the physiology of consciousness and predicting the reversibility of comatose states.
Conditions
- Hepatic Encephalopathy
- Cirrhosis
- Nonalcoholic Steatohepatitis
- Hepatitis C
Sponsors & Collaborators
-
OSF Healthcare System
lead OTHER
Principal Investigators
-
Nisha Bhatia, MD · OSF Healthcare System
-
Hrachya Nersesyan, MD · OSF Healthcare System
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2014-10-31
- Completion
- 2015-02-28
Countries
- United States
Study Locations
More Related Trials
-
Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke
NCT01829386 ·Status: COMPLETED
-
7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy
NCT06923254 ·Status: NOT_YET_RECRUITING
-
Application of 18F-FDOPA PET in Research of the Association Between HCV Infection and Parkinson's Disease.
NCT04618679 ·Status: UNKNOWN
-
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004577 ·Status: RECRUITING
-
Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
NCT00704327 ·Status: TERMINATED
-
Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System
NCT00424957 ·Status: COMPLETED
-
Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging
NCT01434056 ·Status: UNKNOWN
-
Prediction of Dementia in Parkinson's Disease by Measuring Cerebral Metabolism With PET Scan
NCT02855021 ·Status: UNKNOWN ·Phase: NA
-
Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation
NCT01925196 ·Status: COMPLETED
-
Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions
NCT00970333 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects
NCT05604534 ·Status: RECRUITING
-
Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI.
NCT05355857 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease
NCT00249080 ·Status: COMPLETED
-
Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease
NCT03288909 ·Status: UNKNOWN
-
Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET
NCT07100470 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neurologic Deficits and Recovery in Chronic Subdural Hematoma
NCT05900557 ·Status: WITHDRAWN ·Phase: NA
-
Long-term Cognitive and Cerebral Changes in Sepsis Survivors and Their Predictors
NCT02339649 ·Status: UNKNOWN ·Phase: NA
-
Predicting Stroke Risk in ICAD With Novel MRI
NCT05515874 ·Status: COMPLETED ·Phase: PHASE4
-
Imaging the Pathogenesis of Cerebral Small Vessel Disease
NCT05703386 ·Status: RECRUITING
-
Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias
NCT02945774 ·Status: RECRUITING ·Phase: NA
-
NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease
NCT06453915 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study
NCT04992975 ·Status: RECRUITING
-
Molecular and Functional Imaging in Monogenic PD.
NCT05518617 ·Status: RECRUITING
-
Functional Magnetic Resonance Imaging (fMRI) of Brain in ICU Survivors With Cognitive Impairment
NCT03946839 ·Status: COMPLETED